Macular / Foveal Translocation — CPB 0409 | AETNA Coverage Update

Aetna modified CPB 0409 covering macular/foveal translocation, effective September 26, 2025. Here's what changes for billing teams.

Aetna, a CVS Health company, updated Clinical Policy Bulletin CPB 0409 governing macular/foveal translocation surgery. This coverage policy applies to retinal procedures billed under ICD-10-CM diagnosis codes in the H35.30–H35.3293 range for age-related macular degeneration and H35.51–H35.59 for retinal neovascularization. If your practice bills for retinal surgery under these diagnoses, this update directly affects your claim submission and medical necessity documentation before September 26, 2025.

Quick-Reference Table

Aetna Macular/Foveal Translocation Coverage Criteria and Medical Necessity Requirements 2025

The Aetna macular/foveal translocation coverage policy under CPB 0409 addresses one of the more complex surgical interventions in retinal care. Macular translocation is a surgical procedure that physically repositions the fovea — the center of the retina responsible for sharp central vision — away from diseased tissue. It's rarely performed today compared to its peak use before anti-VEGF therapy became standard, but it still surfaces in specialized retinal practices.

The available CPB 0409 policy summary does not enumerate specific medical necessity criteria, clinical thresholds, or required treatment history. To confirm exact coverage requirements, consult the full CPB 0409 policy document directly through Aetna's provider portal or contact your Aetna provider relations representative. Age-related macular degeneration coded under H35.30 through H35.3293 and retinal neovascularization coded under H35.51 through H35.59 are the primary diagnosis groups in scope under this policy.

Prior authorization requirements are not specified in the CPB 0409 policy summary. That said, confirming prior authorization requirements with your Aetna provider relations contact or your specific plan contract is standard practice for high-cost, low-volume surgical procedures. Check your contract before submission.

The reimbursement exposure on a denied macular translocation claim is significant. These are complex surgical cases with substantial facility and professional fees attached. Getting the medical necessity documentation right before submission matters more here than in most retinal billing scenarios.

Aetna Macular/Foveal Translocation Exclusions and Non-Covered Indications

The policy data for CPB 0409 does not enumerate specific exclusion language in the summary provided. That said, macular translocation has a documented history of being classified as experimental or investigational by multiple payers for indications beyond neovascular AMD — particularly for conditions where anti-VEGF therapy remains the standard of care.

If your patient's diagnosis falls outside the H35.30–H35.3293 AMD range or the H35.51–H35.59 neovascularization codes, expect heightened scrutiny. A claim denial is likely without strong clinical justification in hand.

Talk to your compliance officer if you're billing this procedure for an off-label indication. The financial and compliance risk on an improperly documented macular translocation claim is not trivial.

Coverage Indications at a Glance

Aetna Macular/Foveal Translocation Billing Guidelines and Action Items 2025

Macular/foveal translocation billing has always been technically demanding. This CPB 0409 modification makes it more so. Here's what your team needs to do before the effective date of September 26, 2025.

If you're uncertain how the CPB 0409 modification changes your specific payer mix or contract terms, loop in your billing consultant or compliance officer before the effective date. This is not a policy change to interpret unilaterally.

CPT, HCPCS, and ICD-10 Codes for Macular/Foveal Translocation Under CPB 0409

The policy data for CPB 0409 does not list specific CPT or HCPCS procedure codes. The applicable codes provided are ICD-10-CM diagnosis codes only. Your team should confirm the appropriate CPT surgical codes for macular translocation with your retinal surgery documentation and cross-reference against your Aetna fee schedule. Do not bill CPT codes not supported by your operative report — that's a quick path to a medical necessity denial or an audit flag.

Key ICD-10-CM Diagnosis Codes Under CPB 0409

Use the most specific code your documentation supports. "Unspecified" codes invite additional documentation requests and slow reimbursement. If the operative note specifies laterality and AMD staging, the ICD-10 code on your claim should match exactly.